What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Blood pressure
- Heart failure
Michael A. Weber mostly deals with Internal medicine, Blood pressure, Cardiology, Angiotensin II and Surgery.
His work in Internal medicine tackles topics such as Endocrinology which are related to areas like Arousal.
His Blood pressure research is multidisciplinary, incorporating perspectives in Hemodynamics and Placebo.
He has included themes like Sphygmomanometer and Heart rate in his Cardiology study.
Michael A. Weber interconnects Bradykinin, Angiotensin-converting enzyme and Pharmacology in the investigation of issues within Angiotensin II.
His Surgery research is multidisciplinary, incorporating elements of Essential hypertension and Medical screening.
His most cited work include:
- Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (2246 citations)
- Hemodynamic Patterns of Age-Related Changes in Blood Pressure: The Framingham Heart Study (1774 citations)
- Beta-adrenergic activation and memory for emotional events. (1074 citations)
What are the main themes of his work throughout his whole career to date?
Michael A. Weber spends much of his time researching Internal medicine, Blood pressure, Cardiology, Endocrinology and Anesthesia.
Renin–angiotensin system, Angiotensin II, Plasma renin activity, Heart failure and Hemodynamics are among the areas of Internal medicine where Michael A. Weber concentrates his study.
His Blood pressure study combines topics from a wide range of disciplines, such as Placebo and Surgery.
His work in Placebo covers topics such as Hydrochlorothiazide which are related to areas like Amlodipine.
His Myocardial infarction study in the realm of Cardiology interacts with subjects such as In patient.
Endocrinology is often connected to Pharmacology in his work.
He most often published in these fields:
- Internal medicine (68.48%)
- Blood pressure (69.73%)
- Cardiology (41.96%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (68.48%)
- Blood pressure (69.73%)
- Cardiology (41.96%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Blood pressure, Cardiology, In patient and Stroke.
As part of his studies on Internal medicine, Michael A. Weber often connects relevant areas like Diabetes mellitus.
Specifically, his work in Blood pressure is concerned with the study of Valsartan.
As a part of the same scientific family, Michael A. Weber mostly works in the field of Valsartan, focusing on Urology and, on occasion, Stage and Plasma renin activity.
His work deals with themes such as Adverse effect, Mean blood pressure, Angiotensin-converting enzyme and Confidence interval, which intersect with Cardiology.
His studies examine the connections between Amlodipine and genetics, as well as such issues in Benazepril, with regards to Hydrochlorothiazide.
Between 2011 and 2021, his most popular works were:
- Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. (560 citations)
- Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension (487 citations)
- Global Burden of Cardiovascular Disease and Stroke: Hypertension at the Core (163 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Blood pressure
- Disease
His main research concerns Blood pressure, Internal medicine, Cardiology, Stroke and Randomized controlled trial.
Michael A. Weber studies Blood pressure, focusing on Valsartan in particular.
His Internal medicine study focuses mostly on Hazard ratio, Hydrochlorothiazide, Diastole and Cardiovascular outcomes.
His work on Myocardial infarction as part of general Cardiology research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His biological study spans a wide range of topics, including Surgery and Heart failure.
His Placebo study incorporates themes from Diastolic Hypertension, Lisinopril and Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
